1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Key Pharma News 16 FEBRUARY 2015

Key Pharma News 16 FEBRUARY 2015

  • February 2015
  • -
  • Espicom Business Intelligence
  • -
  • 41 pages

Industry Trend Analysis - New Compounds Fill Pipelines As R&D Expenditure Rises
Industry Trend Analysis - Genzyme/Voyager Deal Demonstrates Gene Therapy's Revival
Industry Trend Analysis - Hospira Eyes Up Lucentis Biosimilar In Deal That Will Threaten Roche/Novartis
Industry Trend Analysis - Acquisition Of Hospira Gives Pfizer Entrance To Biosimilar And Medical Device Markets
Industry Trend Analysis - Further Double-Digit Revenue Growth And Increased EPS For Biogen Idec In 2015
Industry Trend Analysis - AstraZeneca Further Bolsters Respiratory Portfolio
Industry Brief - GSK Receives EU Approval For Three-Part Transaction With Novartis
Industry Brief - AstraZeneca Gains Planning Consent For Global R&D Centre/Corporate HQ In Cambridge
Industry Trend Analysis - Novartis Under Pressure To Maximise Revenue Growth Of GSK's Oncology Portfolio
Industry Trend Analysis - Valeant Uses Cheap Acquisition To Enter Cancer Market
Industry Brief - Endo Completes Auxilium Acquisition
Industry Trend Analysis - GSK Strengthens Early Stage Vaccine Pipeline With GlycoVaxyn Acquisition
Industry Trend Analysis - Mylan's Acquisition Of Abbott's Non-US Generics Business On Track To Complete In Q115
Industry Trend Analysis - Regional Powerhouse Ahead As Sun/Ranbaxy Merger Approaches Conclusion
Industry Brief - Mylan To Acquire Famy Care
Industry Trend Analysis - Pfizer's Approval In BC Set To Give Positive Stroke To Company's Declining Revenues
Industry Brief - FDA Approves Prezcobix For HIV-1
Industry Trend Analysis - Zohydro ER's Abuse-Deterrent Label Delay Will Benefit Purdue
Industry Brief - EC Approves Velcade For MCL
Industry Brief - FDA Approves Imbruvica For WM
Industry Brief - Merck Repatriates Diabetes/Thyroids Portfolio In Russia
Industry Brief - Vyvanse Becomes First FDA-Approved Treatment For Moderate-To-Severe BED In Adults
Industry Brief - FDA Approves First-In-Class Glyxambi For Adults With Type II Diabetes
Industry Brief - FDA Grants Priority Review For Yondelis In Advanced STS
Industry Trend Analysis - Afrezza's US Launch Will Test Appetite For New Insulin Delivery Systems
Industry Trend Analysis - Merck's New Insomnia Medicine Has Limited Commercial Potential
Industry Brief - FDA Approves Lucentis For DR In Patients With DMO
Industry Brief - Chugai Submits Ibandronate NDA In Japan For Osteoporosis
Industry Trend Analysis - US Generic Sorafenib Revenues Will Be Small, But Global Prospects Are Attractive
Industry Brief - Breckenridge Initiates Cabazitaxel Patent Challenge
Industry Trend Analysis - As Biosimilar Adalimumab Progresses, Amgen And AbbVie's Fortunes Cast In Comparative Light
Industry Brief - AbbVie Reports Positive Results From Phase III Study Of All-Oral HCV Treatment In Japan
Industry Trend Analysis - FDA Turns Its Back On Merck For HCV; Repercussions For Achillion
Industry Trend Analysis - Neupro's Expansion Into China Will Boost UCB's Revenues
Industry Brief - FDA Grants Breakthrough Therapy Designation To Genentech's Anti-PDL1 Immunotherapy
Industry Brief - Enrolment Begins In Daiichi Sankyo's Mirogabalin Phase III Programmes
Industry Trend Analysis - Positive Phase II Results Could Lead To Daratumumab's Early Approval
Industry Trend Analysis - Takeda Can Replicate Velcade's Success With Ixazomib
Industry Trend Analysis - Gazyva Likely To Gain NHL Indication Just Ahead Of Vast Increase In Market Size
Industry Trend Analysis - Precision Medicine Initiative Promotes Data-Driven Treatment

Table Of Contents

Key Pharma News 16 FEBRUARY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
R&D Drug Pipeline Database: 1-Year Subscription

R&D Drug Pipeline Database: 1-Year Subscription

  • $ 6600
  • Industry report
  • November 2016
  • by La Merie Publishing

R&D Drug Pipeline Database: 1-Year Subscription Subscription to La Merie Publishing’s proprietary R&D Drug Pieline Database provides 24/7 online access to information about more than 21,000 project entries ...

Cancer Vaccines: Technologies and Global Markets

Cancer Vaccines: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

This cancer vaccines report by BCC Research explores present and future strategies within the market which includes prophylactic vaccines and therapeutic vaccines. Use this report to: - Analyze the global ...

Single-use Bioprocessing Market by Product, Application, End User - Global Forecast to 2021

Single-use Bioprocessing Market by Product, Application, End User - Global Forecast to 2021

  • $ 6328
  • Industry report
  • October 2016
  • by MarketsandMarkets

Rising Biopharmaceutical Demand and Increasing Investments in R&D Activities Drive Growth of the Single-use Bioprocessing Market The global single-use bioprocessing market is projected to reach USD 5.44 ...


Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.